Actively Recruiting
Procedural Framing and Epidural Steroid Injection Outcomes
Led by Northwestern University · Updated on 2026-05-01
210
Participants Needed
2
Research Sites
117 weeks
Total Duration
On this page
Sponsors
N
Northwestern University
Lead Sponsor
P
Phramongkutklao College of Medicine and Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Back pain is the leading cause of disability and military medical boards across the globe. Epidural steroid injections (ESI) are the most commonly performed pain procedure in the world. There is strong evidence that the placebo effect for all pain treatments, including ESI, is greater than the intrinsic effect. The placebo effect is highly dependent on a patient's 'expectations', and therefore how the procedure is framed. This study aims to compare ESI when the procedure is framed very positively- as is often done in clinical practice vs. more neutrally (which is less commonly done in clinical practice but consistent with evidence). The placebo effect is also stronger for procedures than medications. The evidence on the benefits of ESI is highly dependent on whether it is compiled by interventional doctors who perform the procedure or non-interventional researchers. In order to determine how 'framing' a treatment affects pain outcomes, the investigative team will conduct a 3-arm randomized trial comparing positive framing of ESI, neutral framing of ESI, and medications, in patients with lumbosacral radiculopathy.
CONDITIONS
Official Title
Procedural Framing and Epidural Steroid Injection Outcomes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age > 18
- Lumbosacral radicular pain based on history and physical exam (e.g. pain radiating into one or both lower extremities, sensory loss, muscle weakness, positive straight leg raising test etc.)
- Duration of pain >6 weeks
- NRS leg pain score > 4 (or if 3/10, greater or equal to back pain)
- MRI evidence of spinal pathology consistent with symptoms
- Candidates for ESI and pharmacotherapy
You will not qualify if you...
- Untreated coagulopathy
- Previous spine surgery
- No MRI or non-concordant MRI study
- Leg pain > 15 years duration
- Epidural steroid injection within past 2 years
- Signs or symptoms of cauda equina syndrome
- Previous failed trials with gabapentin and pregabalin and tricyclic antidepressants and duloxetine
- Allergic reactions to contrast dye prohibiting injection (e.g., tranforaminal ESI), gabapentinoids, tricyclic antidepressants or duloxetine, and contraindications to all of the above medications
- Referrals from surgery for diagnostic injections for surgical evaluation
- Serious medical (e.g. congestive heart failure) or psychiatric (untreated depression) condition that might preclude optimal outcome
- Pregnancy
- Inability to understand basic English
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Northwestern University
Chicago, Illinois, United States, 60611
Actively Recruiting
2
Walter Reed National Military Medical Center
Bethesda, Maryland, United States, 20814
Enrolling by Invitation
Research Team
S
Steven P Cohen, MD
CONTACT
J
Jordan Wood, BS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here